Get started
Author

Nassip C Llerena Navarro

Observed names: Llerena, Nassip, Nassip C. Llerena Navarro, Nassip Llerena, Nassip Llerena Navarro
Institution: EsSALUD
Observed institution: EsSALUD
OpenAlex ID: A5056866100
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
2019 · Kausik K Ray, Helen M Colhoun, et al. · The Lancet Diabetes & Endocrinology · 315
PDF
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021 · Gregory G. Schwartz, Michael Szarek, et al. · Journal of the American College of Cardiology · 150
PDF
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
2022 · Emil Hagström, P. Gabriel Steg, et al. · Circulation · 118
PDF
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry
2023 · Giulio Francesco Romiti, Bernadette Corica, et al. · EClinicalMedicine · 46
PDF
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
2021 · Gregory G. Schwartz, Michael Szarek, et al. · Diabetes Care · 40
PDF
The impact of obesity on left ventricular hypertrophy and diastolic dysfunction in children and adolescents
2021 · Joanna Bartkowiak, Ernest Spitzer, et al. · Scientific Reports · 38
PDF
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
2022 · Gregory Y. H. Lip, Agnieszka Kotalczyk, et al. · Clinical Research in Cardiology · 33
PDF
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
2025 · P. Gabriel Steg, Michael Szarek, et al. · Circulation · 28
PDF
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
2024 · Shaun G Goodman, Philippe Gabriel Steg, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 25
PDF
Screening for Rheumatic Heart Disease among Peruvian Children: A Two-Stage Sampling Observational Study
2015 · Ernest Spitzer, Jorge Mercado, et al. · PLoS ONE · 22
PDF
Características epidemiológicas del infarto de miocardio con elevación del segmento ST en Perú: resultados del PEruvian Registry of ST-segment Elevation Myocardial Infarction (PERSTEMI)
2018 · Manuel Chacón-Diaz, Alejandro Vega, et al. · Archivos de cardiología de México · 21
PDF
Tratamiento del infarto agudo de miocardio en el Perú y su relación con eventos adversos intrahospitalarios: resultados del Segundo Registro Peruano de Infarto de Miocardio con elevación del segmento ST (PERSTEMI-II)
2021 · Manuel Chacón-Diaz, René Rodríguez Olivares, et al. · Archivos Peruanos de Cardiología y Cirugía Cardiovascular · 10
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
2023 · Wern Yew Ding, Ameenathul Mazaya Fawzy, et al. · Journal of Thrombosis and Thrombolysis · 7
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry
2020 · George Ntaios, Menno V. Huisman, et al. · Hellenic Journal of Cardiology · 3
PDF
Echocardiographic nomograms in children living at high altitude according to sex
2025 · Demeke Mekonnen, Claire B Ren, et al. · European Heart Journal - Imaging Methods and Practice
PDF
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
2022 · Gregory Y. H. Lip, Agnieszka Kotalczyk, et al. · Clinical Research in Cardiology
PDF
Características epidemiológicas del infarto de miocardio con elevación del segmento ST en Perú: resultados del Peruvian Registry of ST-segment Elevation Myocardial Infarction (PERSTEMI)
2018 · Manuel Chacon Diaz, Alejandro de la Vega, et al.
Works count: 18
Citation count: 856
H-index: 11
I10-index: 12
Year
Topic
Type